{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:44:44Z","timestamp":1792511084592,"version":"4.5.0"},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2026,10,20]]},"DOI":"10.1001\/jama.2026.14700","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:30:28Z","timestamp":1790177428000},"page":"1377","source":"Crossref","is-referenced-by-count":0,"title":["Lifestyle Modification and Incretin Therapy for Individuals With Obesity\u2014Reply"],"prefix":"10.1001","volume":"336","author":[{"given":"Robert F.","family":"Kushner","sequence":"first","affiliation":[{"name":"Departments of Medicine and Medical Education, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana M.","family":"Chao","sequence":"additional","affiliation":[{"name":"Johns Hopkins School of Nursing, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Wadden","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"24","key":"jlr260085r1","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1001\/jama.2026.4106","article-title":"Lifestyle modification and incretin-based therapy for obesity.","volume":"335","author":"Kushner","year":"2026","journal-title":"JAMA"},{"key":"jlr260085r2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2025-005729","article-title":"Pharmacologic treatment of obesity in adults: standards of care in overweight and obesity.","volume":"13","author":"American Diabetes Association Professional Practice Committee for Obesity","year":"2026","journal-title":"BMJ Open Diabetes Res Care"},{"key":"jlr260085r3","doi-asserted-by":"publisher","DOI":"10.7326\/ANNALS-25-02714","article-title":"Pharmacologic treatments with lifestyle modifications in nonpregnant adults with overweight or obesity in outpatient settings: a living clinical guideline from the American College of Physicians (April 2026).","author":"Qaseem","year":"2026","journal-title":"Ann Intern Med"},{"issue":"4","key":"jlr260085r4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/oby.70164","article-title":"Joint TOS\/OMA\/OAC expert guidance statement on the pharmacological management of United States adults with overweight or obesity using the GRADE approach.","volume":"34","author":"Alexander","year":"2026","journal-title":"Obesity (Silver Spring)"},{"key":"jlr260085r5","unstructured":"Harley? S, ed. New obesity guidance urges dietitian-led care as GLP-1 drugs reshape treatment. Medical Xpress. May 15, 2026. Accessed July 17, 2026. https:\/\/medicalxpress.com\/news\/2026-05-obesity-guidance-urges-dietitian-glp.html"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2854451\/jama_kushner_2026_lr_260085_1791561682.12355.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:00:52Z","timestamp":1792508452000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2854451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":5,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026,10,20]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2026.14700","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,20]]}}}